About Lunsford Capital
Lunsford Capital is a venture capital firm founded in 2003. It is primarily based out of Louisville, United States. As of Jul 2022, Lunsford Capital has invested in 34 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Seed round of Resound Overall, Lunsford Capital portfolio has seen 2 IPOs and 13 acquisitions including key companies like Rubicon, Sprout Pharmaceuticals and Ventasreit. A lot of funds co-invest with Lunsford Capital, with names like Render Capital sharing a substantial percentage of its portfolio. Lunsford Capital has team of 2 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 1 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Lunsford Capital's List of Top Investments
Lunsford Capital has a portfolio of 34 companies. Their most notable investments are in Phyt.health and GoWild.Their portfolio spans across United States, Australia and India. They have invested in Enterprise Applications, HealthTech, Life Sciences and 13 other sectors, across stages such as Seed, Series A and 1 more. Here is the list of top investments by Lunsford Capital:
1. Wellthy
Online platform to guide families and patients with long term health conditions. It provides care concierge for caregivers with a digital dashboard and real-time advice from care experts, health plans to enhance care management and improve the member experience.
Key facts about Wellthy
- Founded Year: 2014
- Location: New York City (United States)
- Stage: Series B
- Total Funding till date: $80M
- Employee Count: 301 as on Feb 28, 2026
- Investors: India Infoline, Workday Ventures and 23 Others
- Latest Funding Round: Series B, May 11, 2023, $*****
- Highlight: Editors' Pick
2. Rubicon
Provider of waste and recycling management solutions for various businesses. The company offers services to manage waste, control costs, and provide support. It delivers transparency, convenience, and real-time data through a tech-enabled approach. The company offers services such as site audits, material recovery plans, and zero waste program design.
Key facts about Rubicon
- Founded Year: 2008
- Location: Portland (United States)
- Annual Revenue: $698M as on Dec 31, 2023
- Stage: Public
- Total Funding till date: $272M
- Employee Count: 537 as on Mar 31, 2026
- Investors: Wellington, Goldman Sachs and 25 Others
- Latest Funding Round: Post IPO, Jan 10, 2024, $*****
- Highlight: Public
Sprout Pharmaceuticals has developed drugs for women's health. The company has developed an FDA-approved non-hormonal pill called ADDYI to cure Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Key facts about Sprout Pharmaceuticals
- Founded Year: 2011
- Location: Raleigh (United States)
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $185M
- Employee Count: 31 as on Feb 28, 2026
- Investors: New Ventures Funds, Lunsford Capital and 1 Other
- Latest Funding Round: Series D, Dec 10, 2024, $*****
- Highlight: Acquired
4. Ventasreit
Ventas is a seniors housing and healthcare real estate investment trust in the United States, Canada, and United Kingdom. The company acquires, develops, leases disposes of, manages and operates senior housing and healthcare real estate facilities. Their clientele includes individuals and business. In 2023, the company recorded annual revenues of $4.13B and a net loss of $0.05B.
Key facts about Ventasreit
- Founded Year: 1998
- Location: Chicago (United States)
- Annual Revenue: $4.92B as on Dec 31, 2024
- Stage: Public
- Employee Count: 805 as on Mar 31, 2026
- Investors: Seaside Private Capital and Lunsford Capital
- Latest Funding Round: Conventional Debt, Mar 13, 2017, $*****
- Highlight: Public
5. Navitas
Provider of pathway programs, English language courses, and degree qualifications. The organisation delivers educational programs through colleges and campuses. It offers various study options, including degrees, diplomas, certificates, and employability training. The organisation connects students, agents, universities, and industry for international higher education.
Key facts about Navitas
- Founded Year: 1994
- Location: Perth (Australia)
- Annual Revenue: ₹29.6Cr as on Mar 31, 2025
- Last Known Valuation: $*****
- Stage: Acquired
- Employee Count: 125 as on Feb 29, 2024
- Investors: Ontario Teachers' Pension Plan, YX Capital and 6 Others
- Latest Funding Round: Grant (prize money), Feb 01, 2019, $*****
- Highlight: Acquired
Lunsford Capital's Year-on-Year Investment Trends
Lunsford Capital has invested in 34 companies over the last 19 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Resound and most recent follow-on round was in Astarte Medical.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 1 | 0 | 1 |
2021 | 2 | 1 | 3 |
2020 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2018 | 0 | 1 | 1 |
Lunsford Capital's Investments by Stage
Lunsford Capital has made 3 investments in Seed stage with an average round size of $1.5M, 3 investments in Series A stage with an average round size of $3.9M and 1 investment in Series E stage with an average round size of $7.1M.Stage of entry | No. of Investments |
|---|---|
Seed | 3 |
Series A | 3 |
Series E | 1 |
Note: We have considered here, only first round of investments
Lunsford Capital's Investments by Sector
Lunsford Capital has a diverse portfolio, with companies operating in the Enterprise Applications, Consumer, HealthTech, Media & Entertainment and Retail. Notably, it has invested in 18 Tech companies, 17 Enterprise (B2B) companies, 11 Software companies and at least 10 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 3 |
Consumer | 2 |
HealthTech | 2 |
Media & Entertainment | 2 |
Retail | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
Lunsford Capital's Investments by Geography
Lunsford Capital has made most investments in United States (6), followed by India where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 6 |
India | 1 |
Note: We have considered here, only first round of investments
Lunsford Capital's recent investments
Lunsford Capital has not made any investment in 2026 so far.Here are the most recent investments by Lunsford Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jul 18, 2022 | United States | Seed | 1618 | [+6] | |
Dec 07, 2021 | India | Seed | 4541 | - | |
Nov 02, 2021 | United States | Series A | 6412 | [+6] | |
Sep 22, 2021 | United States | Series A | 8674 | ||
Jan 29, 2020 | United States | Seed | 2914 | [+4] |
IPOs and Publicly Listed companies in Lunsford Capital's Portfolio
2 of Lunsford Capital's portfolio companies have become public. Rubicon got listed on the New York Stock Exchange (NYSE), in Dec 2021 at marketcap of undefined and Ventasreit got listed on the New York Stock Exchange (NYSE) at marketcap of undefined.Here are Lunsford Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 10, 2021 | - | - | 9104 | |
Nov 27, 2009 | - | - | 3392 |
Acquired companies in Lunsford Capital's Portfolio
13 companies from Lunsford Capital's portfolio have been acquired. The most recent acquisition were SentryHealth in Nov 2023 by First Stop Health.Here are Lunsford Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Nov 02, 2023 | Dec 09, 2015 | Series A | 1618 | |
Oct 04, 2023 | Jun 19, 2007 | Series E | 2424 | |
Aug 09, 2022 | - | - | 5925 | |
Jul 18, 2022 | Jan 29, 2020 | Seed | 9844 | |
Jul 06, 2022 | - | - | 3455 |
Team profile of Lunsford Capital
Lunsford Capital has a team of 2 members including 1 Partner and 1 Principal located in United States. Lunsford Capital's team does not sit on the board of any company as of now.Co-investors of Lunsford Capital
Over the past 19 years, 54 investors have co-invested in Lunsford Capital's portfolio companies. This includes funds and angels.
- Invested before Lunsford Capital: Ben Franklin Technology Partners, Next Act Fund and 9 others have invested in rounds before Lunsford Capital. There is 1 company where Ben Franklin Technology Partners has invested before Lunsford Capital and 1 company where Next Act Fund has invested before Lunsford Capital.
- Top Co-investors of Lunsford Capital: 25 investors entered a company along with Lunsford Capital. These include investors like Render Capital (2 companies).
- Invested after Lunsford Capital: A total of 18 investors have invested in Lunsford Capital's portfolio after their investments. Top Investors include LEATHERNECK VENTURES, LLC (1 company), socialventurecircle.com (1 company) and Ben Franklin Technology Partners (1 company).
Recent News related to Lunsford Capital
•
Phyt.health raises $1.5 M in seed fund from US-based LunsfordBioSpectrum India•Dec 07, 2021•Phyt.health, Lunsford Capital
•
Medtech raises $7.6M to advance feeding technology for premature infantsThe Business Journals•Oct 02, 2021•Astarte Medical, Lunsford Capital, Ben Franklin Technology Partners, OCA Ventures and 3 others
•
Podchaser lands seed funding of $1.65 millionRAIN News•Jan 29, 2020•Podchaser, OAKS, Hyde Park Venture Partners, Poplar Ventures and 2 others
•
•
Edumedics Closes $4.2 Million Series A Financing | EdumedicsEdumedics•Dec 09, 2015•Edumedics, Lunsford Capital, OCA Ventures, Enterprise Angels Community Fund I and 2 others
•
Edumedics closes $4.2 million Series A funding - Insider LouisvilleInsider Louisville•Dec 09, 2015•Edumedics, Lunsford Capital, OCA Ventures, Enterprise Angels Community Fund I and 2 others
•
